Updated cost-effectiveness analysis of supplemental glutamine for parenteral nutrition of intensive-care patients

European Journal of Clinical Nutrition

Volumn 69, Issue 5, 2015, Pages 546-551

  Pradelli, L ^a   Povero, M ^a   Muscaritoli, M ^b   Eandi, M ^c  

^a AdRes Health Economics and Outcomes Research   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLGLUTAMINE; GLUTAMINE;

ARTICLE; COMPARATIVE EFFECTIVENESS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE QUALITY; HOSPITAL COST; HUMAN; INTENSIVE CARE; ITALY; LENGTH OF STAY; META ANALYSIS (TOPIC); MORTALITY; PARENTERAL NUTRITION; SENSITIVITY ANALYSIS; SUPPLEMENTATION; COST BENEFIT ANALYSIS; DIET THERAPY; DIETARY SUPPLEMENT; ECONOMICS; INFECTION; INTENSIVE CARE UNIT; MALE; PROCEDURES; STATISTICS AND NUMERICAL DATA;

COST-BENEFIT ANALYSIS; CRITICAL CARE; DIETARY SUPPLEMENTS; GLUTAMINE; HUMANS; INFECTION; INTENSIVE CARE UNITS; ITALY; LENGTH OF STAY; MALE; PARENTERAL NUTRITION;

EID: 84929050168     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2014.255     Document Type: Article

References (25)

1. Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel HJ, Zandstra DF. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intens Care Med 2001; 27: 84-90.
2. Rodas PC, Rooyackers O, Hebert C, Norberg A, Wernerman J. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci (Lond) 2012; 122: 591-597.
3. Dipeptiven (L-alanyl-L-glutamine). Summary of Product Characteristics. Fresenius Kabi, Bad Homburg, 2011.
4. Albers S, Wernerman J, Stehle P, Vinnars E, Furst P. Availability of amino acids supplied intravenously in healthy man as synthetic dipeptides: kinetic evaluation of L-alanyl-L-glutamine and glycyl-L-tyrosine. Clin Sci (Lond) 1988; 75: 463-468.
5. Bollhalder L, Pfeil AM, Tomonaga Y, Schwenkglenks M. A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clin Nutr 2012; 32: 213-223.
6. Pradelli l, Iannazzo S, Zaniolo O, Muscaritoli M, Eandi M. Effectiveness and cost-effectiveness of supplemental glutamine dipeptide in total PN therapy for critically ill patients: a discrete event simulation model based on Italian data. Int J Technol Assess Health Care 2012; 28: 22-28.
7. Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A et al. ESPEN guidelines on PN: intensive care. Clin Nutr 2009; 28: 387-400.
8. McClave SA, Martindale RG, Vanek VW, McCarthy M, Roberts P, Taylor B et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). J Parenter Enteral Nutr 2009; 33: 277-316.
9. Progetto MARGHERITA-Rapporto 2010. Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva (GIVITI). Sestante Edizioni: Bergamo, 2011.
10. Progetto MARGHERITA-Rapporto 2007. Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva (GIVITI). Sestante Edizioni: Bergamo, 2008.
11. Malacarne P, Rossi C, Bertolini G. Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study. J Antimicrob Chemother 2004; 54: 221-224.
12. Boffelli S, Rossi C, Anghileri A, Giardino M, Carnevale L, Messina M et al. Continuous quality improvement in intensive care medicine: the GiViTI Margherita project-report 2005. Miner Anestesiol 2006; 72: 419-432.
13. Galzerano A, Sabatini E, Duri D. Old patients in intensive care unit (ICU): What decisions to make? Arch Gerontol Geriatr 2009; 49: 294-297.
14. Poole D, Rossi C, Anghileri A, Giardino M, Latronico N, Radrizzani D et al. External validation of the Simplified Acute Physiology Score (SAPS) 3 in a cohort of 28, 357 patients from 147 Italian intensive care units. Intens Care Med 2009; 35: 1916-1924.
15. Bertolini G, Boffelli S, Malacarne P, Peta M, Marchesi M, Barbisan C et al. End-of-life decision-making and quality of ICU performance: an observational study in 84 Italian units. Intens Care Med 2010; 36: 1495-1504.
16. Tarricone R, Torbica A, Franzetti F, Rosenthal VD. Hospital costs of central line-associated bloodstream infections and cost-effectiveness of closed vs open infusion containers. The case of intensive care units in Italy. Cost Eff Resour Alloc 2010; 8: 8.
17. Orsi GB, Di Stefano L, Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol 2002; 23: 190-197.
18. Agenzia Nazionale per i Servizi Sanitari Regionali (ASSR). Ricoveri, personale e spesa delle aziende ospedaliere (2003) http://www.agenas.it/images/agenas/monitor/pdf/Monitor-16.pdf (last access November 2013).
19. European Commission. EuroStat 2012: http://epp.eurostat.ec.europa.eu/portal/page/portal/hicp/data/database (last access November 2013).
20. Mertes N, Schulzki C, Goeters C, Winde G, Benzing S, Kuhn KS et al. Cost containment through L-alanyl-L-glutamine supplemented total PN after major abdominal surgery: a prospective randomized double-blind controlled study. Clin Nutr 2000; 19: 395-401.
21. Zhou Y-P, Jiang Z-M, Sun Y-H, He G-Z, Shu H. The effects of supplemental glutamine dipeptide on gut integrity and clinical outcome after major escharectomy in severe burns: a randomized, double-blind, controlled clinical trial. Clin Nutr Suppl 2004; 1: 55-60.
22. Wang Y, Jiang Z-M, Nolan MT, Jiang H, Han HR, Yu K et al. The impact of glutamine dipeptide-supplemented parenteral nutrition on outcomes of surgical patients: a meta-analysis of randomized clinical trials. J Parenter Enteral Nutr 2010; 34: 521-529.
23. Zheng Y-M, Li F, Zhang M-M, Wu X-T. Glutamine dipeptide for parenteral nutrition in abdominal surgery: a meta-analysis of randomized controlled trials. World J Gastroenterol 2006; 12: 7537-7541.
24. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002; 30: 2022-2029.
25. Buxton MJ, Drummond MF, Van Hout BA, Prince RL, Sheldon TA, Szucs T et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997; 6: 217-227.